Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 5 , Pages 384-388, September 2009

Apolipoprotein E, Alcohol Consumption, and Risk of Ischemic Stroke: The Framingham Heart Study Revisited

  • Luc Djoussé, MD, DSc

      Affiliations

    • Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationAddress correspondence to Luc Djoussé, MD, MPH, DSc, FAHA, Division of Aging, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, 3rd Floor, Boston, MA 02120.
  • ,
  • Jayandra J. Himali, MS

      Affiliations

    • Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts
    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
  • ,
  • Alexa Beiser, PhD

      Affiliations

    • Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts
    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
    • Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
  • ,
  • Margaret Kelly-Hayes, EdD, RN

      Affiliations

    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
    • Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
  • ,
  • Philip A. Wolf, MD

      Affiliations

    • National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts
    • Department of Neurology, Boston University School of Medicine, Boston, Massachusetts

Received 11 December 2008; received in revised form 13 January 2009; accepted 20 January 2009.

Background

Data on the association between alcohol consumption and ischemic stroke have been inconsistent. It is not known whether allele ɛ4 of the apolipoprotein E (apoE) gene modifies the alcohol-stroke association. We sought to examine whether ɛ4 allele of the apoE gene influences the association between alcohol consumption and ischemic stroke or high-density lipoprotein (HDL) cholesterol.

Methods

We examined a cohort of 7676 person-observations of the Framingham Heart Study. Incident stroke was ascertained by standardized methods. We used Cox proportional hazard model to estimate hazard ratios of ischemic stroke.

Results

The average age at baseline was 63 years and 55% of the participants were women. During a mean follow-up of 7.4 years, 222 new cases of ischemic stroke occurred (56 embolic and 166 atherothrombotic events). Comparing current drinkers with nondrinkers, multivariable adjusted hazard ratio (95% confidence interval) for ischemic stroke was 0.50 (0.24-1.07) in the absence of ɛ4 allele and 0.70 (0.24-2.05) in the presence of ɛ4 allele (P for interaction = .64) for those younger than 65 years. Similarly, we did not observe a statistically significant interaction between ɛ4 allele and alcohol consumption on the risk of stroke among people aged 65 years and older (P for interaction = .17). Alcohol consumption was positively associated with HDL cholesterol independent of ɛ4 allele and age.

Conclusions

Our data do not provide evidence for an interaction between ɛ4 allele and alcohol consumption on the risk of ischemic stroke in this population. Furthermore, apoE polymorphism did not influence the alcohol-HDL relation.

Key Words: Alcohol drinking, ischemic stroke, apolipoprotein E gene, lipids

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the National Heart, Lung, and Blood Institute's (NHLBI) Framingham Heart Study contract No. N01-HC-25195, National Institute of Health, Bethesda, MD, and a grant from the National Institute of Neurological Disorders and Stroke (5RO1-NS 017950, Philip A. Wolf, MD, Principal Investigator). Dr. Djoussé was partially supported by K01 HL-70444 from the NHLBI.

PII: S1052-3057(09)00023-8

doi:10.1016/j.jstrokecerebrovasdis.2009.01.008

Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 5 , Pages 384-388, September 2009